A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

Researchers shed light on the "dark matter" of the gut, revealing a species of fungus that could potentially help counter ...

Researchers identified a rare variant on a single gene that appears to predispose patients to metabolic ...

Obesity causes temporary disruptions, but not permanent structural changes, in the liver’s molecular network that regulates ...

A new study reveals that a single gene plays a big role in how the liver stores energy, a process that's critical for overall health and for managing diseases like type 2 diabetes. The research ...

A groundbreaking study from the University of Oklahoma reveals that the hormone FGF21 can reverse fatty liver disease by ...

A personalized gene editing therapy was successfully used to treat an infant with CPS1 deficiency, a disease that causes ...

A pioneering research study details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works primarily by signaling the brain to ...

Discover a study which explores the impact of MASLD on pregnancy, from preconception to postpartum. Learn more.

A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.

While we focus on a large-scale basis on immunisation and infectious diseases in children, the awareness about metabolic ...